PLoS ONE · 2016 · 30 citations · 17 references
MedicineNuclear MedicineOncologyDiagnostic ImagingDiagnostic Nuclear MedicineDiagnostic RadiologyMagnetic Resonance ImagingMedical ImagingPositron Emission TomographyProstate Cancer ImagingTumor CharacterizationTumor ImagingAccuracyImage Acquisition QualityPet AcquisitionPet Image ReconstructionPet QuantificationPsma-pet ImagingRadiotracer Uptake QuantificationTumor Uptake Kinetics
OBJECTIVE: The aim of this optimization study was to minimize the acquisition time of 68Ga-HBED-CC-PSMA positron emission tomography/magnetic resonance imaging (PET/MRI) in patients with local and metastatic prostate cancer (PCa) to obtain a sufficient image quality and quantification accuracy without any appreciable loss. METHODS: Twenty patients with PCa were administered intravenously with the 68Ga-HBED-CC-PSMA ligand (mean activity 99 MBq/patient, range 76-148 MBq) and subsequently underwent PET/MRI at, on average, 168 min (range 77-320 min) after injection. PET and MR imaging data were acquired simultaneously. PET acquisition was performed in list mode and PET images were reconstructed at different time intervals (1, 2, 4, 6, 8, and 10 min). Data were analyzed regarding radiotracer uptake in tumors and muscle tissue and PET image quality. Tumor uptake was quantified in terms of the maximum and mean standardized uptake value (SUVmax, SUVmean) within a spherical volume of interest (VOI). Reference VOIs were drawn in the gluteus maximus muscle on the right side. PET image quality was evaluated by experienced nuclear physicians/radiologists using a five-point ordinal scale from 5-1 (excellent-insufficient). RESULTS: Lesion detectability linearly increased with increasing acquisition times, reaching its maximum at PET acquisition times of 4 min. At this image acquisition time, tumor lesions in 19/20 (95%) patients were detected. PET image quality showed a positive correlation with increasing acquisition time, reaching a plateau at 4-6 min image acquisition. Both SUVmax and SUVmean correlated inversely with acquisition time and reached a plateau at acquisition times after 4 min. CONCLUSION: In the applied image acquisition settings, the optimal acquisition time of 68Ga-PSMA-ligand PET/MRI in patients with local and metastatic PCa was identified to be 4 min per bed position. At this acquisition time, PET image quality and lesion detectability reach a maximum while SUVmax and SUVmean do not change significantly beyond this time point.
17
Prostate-specific membrane antigen expression in normal and malignant human tissues.
Donald Silver, I Pellicer, W R Fair et al. · PubMed · 1997 · 1.5K citations
Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 974 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
David G. Bostwick, Anna Pacelli, Michael L. Blute et al. · Cancer · 1998 · 702 citations
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
Ron Israeli, C. Thomas Powell, William R. Fair et al. · PubMed · 1993 · 532 citations